comparemela.com

Latest Breaking News On - Company universal registration document - Page 5 : comparemela.com

Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023

Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMerck seronoNicolas fossiezThomas kuhnManavarere arthur rouillSumitomo pharmaCompany universal registration documentFinancial pressEuropean patent officeInvestor relations corporate communicationsUs patent officeChief executive officerNine months ended septemberUniversal registrationLong term studyJapanese type

Clariane : Résultats T3 2023 Présentation -October 25, 2023 at 07:48 am EDT

2023 Q3 revenue 25 October 2023 Philippe Garin - Chief Financial Officer .

Company universal registration documentGroup universal registration documentUniversal registration document

Clariane: Revenue for the Nine Months Ended 30 September 2023, Solid Revenue Growth in the First Nine Months of the Year

Clariane: Revenue for the Nine Months Ended 30 September 2023, Solid Revenue Growth in the First Nine Months of the Year
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Champagne ardenneFrance generalUnited kingdomThe netherlandsCharles rungeardFlorian bacheletIndiens wirtschaftJulie maryIhre chancenPhilippe garinSophie boissardGroup healthcareCompany universal registration documentUn sustainable development goalsHealth careGroup universal registration document

Poxel Reports Financial Results for First Half 2023 and Provides a Corporate Update

LYON, France, September 26, 2023 Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced its financial results for the period ended June 30, 2023 and provided a corporate update.

France generalNew yorkUnited statesKhoso baluchMerck seronoSumitomo pharmaManavarere arthur rouillThomas kuhnSophie bozecNicolas fossiezFinancial pressEuropean patent officeCommunity weekendInternational meetingAlex leukodystrophy charityMeeting of the japanese diabetes society

SMCP adjusts its 2023 annual guidance

Press release - Paris, September 18th, 2023 Adjustment of annual guidance in a deteriorated economic environment SMCP, parent company of the brands Sandro, Maje, Claudie Pierlot and Fursac, adjusts.

France generalClaudie pierlotEvelyne chetriteJudith milgromCompany universal registration documentFrench financial markets authority autoritUniversal registration documentFrench financial markets authorityDes marchEuronext paris

vimarsana © 2020. All Rights Reserved.